Total Payments
$3,260
2024 Payments
$863.63
Companies
38
Transactions
205
Medicare Patients
2,641
Medicare Billing
$368,036
Payment Breakdown by Category
Food & Beverage$3,127 (95.9%)
Other$133.25 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,127 | 204 | 95.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $133.25 | 1 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $963.73 | 60 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $484.82 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $290.57 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $212.54 | 13 | $0 (2024) |
| PFIZER INC. | $158.17 | 16 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $133.25 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $90.71 | 4 | $0 (2024) |
| GENZYME CORPORATION | $77.75 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $74.53 | 5 | $0 (2024) |
| Celgene Corporation | $69.01 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $863.63 | 47 | ABBVIE INC. ($321.53) |
| 2023 | $699.68 | 38 | ABBVIE INC. ($253.81) |
| 2022 | $154.17 | 8 | ABBVIE INC. ($101.11) |
| 2021 | $32.73 | 2 | AbbVie Inc. ($32.73) |
| 2020 | $260.33 | 17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($110.66) |
| 2019 | $614.91 | 50 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($169.48) |
| 2018 | $480.50 | 30 | FUJIFILM Medical Systems USA, Inc. ($133.25) |
| 2017 | $153.98 | 13 | Takeda Pharmaceuticals America, Inc. ($54.39) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Gastroenterology | ||||||
| 09/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: HEMATOLOGY | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Oncology | ||||||
| 07/30/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: GI | ||||||
| 07/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 07/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Immunology | ||||||
| 06/25/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Gastroenterology | ||||||
| 06/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 808 | 6,184 | $766,608 | $171,507 |
| 2022 | 13 | 576 | 684 | $308,833 | $66,236 |
| 2021 | 12 | 628 | 714 | $294,806 | $70,845 |
| 2020 | 14 | 629 | 682 | $271,015 | $59,448 |
Total Patients
2,641
Total Services
8,264
Medicare Billing
$368,036
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 12 | 4,800 | $312,009 | $68,431 | 21.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 130 | 130 | $147,940 | $25,798 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 236 | $59,000 | $20,860 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $24,272 | $8,109 | 33.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 70 | 70 | $38,220 | $6,042 | 15.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 106 | $13,568 | $5,049 | 37.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 29 | 128 | $12,800 | $4,755 | 37.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 122 | $11,834 | $4,369 | 36.9% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 43 | $11,567 | $3,992 | 34.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 21 | 109 | $8,938 | $3,339 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 53 | $9,381 | $3,224 | 34.4% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 59 | $8,319 | $3,063 | 36.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 14 | 14 | $10,248 | $2,429 | 23.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 67 | $7,437 | $2,425 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 32 | $8,960 | $1,771 | 19.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $40,761 | $1,574 | 3.9% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 15 | 15 | $3,705 | $1,188 | 32.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $13,560 | $1,034 | 7.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $5,841 | $1,026 | 17.6% |
| 43450 | Dilation of esophagus | Facility | 2023 | 33 | 33 | $10,296 | $1,010 | 9.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 21 | $4,704 | $1,009 | 21.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,640 | $783.90 | 29.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 16 | 16 | $608.00 | $227.52 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 226 | $47,485 | $20,738 | 43.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 103 | 104 | $118,352 | $18,483 | 15.6% |
About Dr. Aaron Knoll, MD
Dr. Aaron Knoll, MD is a Gastroenterology healthcare provider based in Beavercreek, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669468690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Knoll, MD has received a total of $3,260 in payments from pharmaceutical and medical device companies, with $863.63 received in 2024. These payments were reported across 205 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,127).
As a Medicare-enrolled provider, Knoll has provided services to 2,641 Medicare beneficiaries, totaling 8,264 services with total Medicare billing of $368,036. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Beavercreek, OH
- Active Since 09/26/2005
- Last Updated 08/24/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1669468690
Products in Payments
- XIFAXAN (Drug) $317.82
- RINVOQ (Biological) $305.63
- STELARA (Biological) $190.08
- DUPIXENT (Biological) $168.46
- XELJANZ (Drug) $148.27
- ESD - Core Endoscopy (Device) $133.25
- ENTYVIO (Biological) $129.26
- VIBERZI (Drug) $119.95
- Entyvio (Biological) $113.13
- CREON (Drug) $97.87
- SKYRIZI (Biological) $93.36
- TRULANCE (Drug) $93.32
- LINZESS (Drug) $92.15
- Humira (Biological) $91.33
- Amitiza (Drug) $77.04
- HUMIRA (Biological) $75.48
- INJECTAFER (Drug) $74.53
- ZEPOSIA (Drug) $69.01
- Creon (Drug) $56.62
- Mavyret (Drug) $48.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Beavercreek
Ben Thomas, D.o, D.O
Gastroenterology — Payments: $14,562
Gastroenterology $14,562
Dr. Ilyas Ikramuddin, D.o, D.O
Gastroenterology — Payments: $4,175
Gastroenterology $4,175
Dr. Michael Gorsky, M.d, M.D
Gastroenterology — Payments: $3,943
Gastroenterology $3,943
Dr. Steven Dellon, M.d, M.D
Gastroenterology — Payments: $2,950
Gastroenterology $2,950
Dr. Azaan Akbar, D.o, D.O
Gastroenterology — Payments: $2,894
Gastroenterology $2,894
Niaz Usman, M.d, M.D
Gastroenterology — Payments: $2,453
Gastroenterology $2,453